BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33667986)

  • 1. IL-10 derived from Hepatocarcinoma cells improves human induced regulatory T cells function via JAK1/STAT5 pathway in tumor microenvironment.
    Zhang S; Gan X; Qiu J; Ju Z; Gao J; Zhou J; Shi C; Zhu Y; Li Z
    Mol Immunol; 2021 May; 133():163-172. PubMed ID: 33667986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-small-cell lung cancer-induced immunosuppression by increased human regulatory T cells via Foxp3 promoter demethylation.
    Ke X; Zhang S; Xu J; Liu G; Zhang L; Xie E; Gao L; Li D; Sun R; Wang F; Pan S
    Cancer Immunol Immunother; 2016 May; 65(5):587-99. PubMed ID: 27000869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accumulation of FoxP3+ T regulatory cells in the tumor microenvironment of human colorectal adenomas.
    Hua W; Yuan A; Zheng W; Li C; Cui J; Pang Z; Zhang L; Li Z; Goll R; Cui G
    Pathol Res Pract; 2016 Feb; 212(2):106-12. PubMed ID: 26724144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.
    Zhang HH; Mei MH; Fei R; Liu F; Wang JH; Liao WJ; Qin LL; Wei L; Chen HS
    J Viral Hepat; 2010 Mar; 17 Suppl 1():34-43. PubMed ID: 20586932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCL4 promoted the production of CD4
    Xu T; Zhao J; Wang X; Meng Y; Zhao Z; Bao R; Deng X; Bian J; Yang T
    Autoimmunity; 2020 Aug; 53(5):289-296. PubMed ID: 32538218
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative analyses of regulatory T cell subsets in patients with hepatocellular carcinoma: a crucial role of CD25(-) FOXP3(-) T cells.
    Kakita N; Kanto T; Itose I; Kuroda S; Inoue M; Matsubara T; Higashitani K; Miyazaki M; Sakakibara M; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
    Int J Cancer; 2012 Dec; 131(11):2573-83. PubMed ID: 22419479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose IL-2 expands CD4
    Li Y; Liu X; Wang W; Wang S; Zhang J; Jiang S; Wang Y; Li L; Li J; Zhang Y; Huang H
    Ren Fail; 2018 Nov; 40(1):280-288. PubMed ID: 29619880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.
    Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL
    J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excreted-secreted antigens of Toxoplasma gondii inhibit Foxp3 via IL-2Rγ/JAK3/Stats pathway.
    Chen J; Huang C; Zhu D; Chen L; Wang J; Sun X; Hu L; Duan Y
    J Cell Biochem; 2018 Dec; 119(12):10176-10185. PubMed ID: 30129110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anti-CXCL4 antibody depletes CD4(+)CD25(+)FOXP3(+) regulatory T cells in CD4+ T cells from chronic osteomyelitis patients by the STAT5 pathway.
    Huang K; Ge S
    Ann Palliat Med; 2020 Sep; 9(5):2723-2730. PubMed ID: 32954739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased regulatory function of CD4
    Sheikh V; Zamani A; Mahabadi-Ashtiyani E; Tarokhian H; Borzouei S; Alahgholi-Hajibehzad M
    Scand J Immunol; 2018 Oct; 88(4):e12711. PubMed ID: 30270447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-10 Potentiates Differentiation of Human Induced Regulatory T Cells via STAT3 and Foxo1.
    Hsu P; Santner-Nanan B; Hu M; Skarratt K; Lee CH; Stormon M; Wong M; Fuller SJ; Nanan R
    J Immunol; 2015 Oct; 195(8):3665-74. PubMed ID: 26363058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The suppressive function of human CD8(+) iTregs is inhibited by IL-1β and TNFα.
    Bjarnadottir U; Lemarquis AL; Halldorsdottir S; Freysdottir J; Ludviksson BR
    Scand J Immunol; 2014 Nov; 80(5):313-22. PubMed ID: 25039313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
    Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
    J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Cellular MicroRNA Facilitates Regulatory T Lymphocyte Development by Targeting the
    Zhang Y; Liu W; Chen Y; Liu J; Wu K; Su L; Zhang W; Jiang Y; Zhang X; Zhang Y; Liu C; Tao L; Liu B; Zhang H
    J Immunol; 2018 Feb; 200(3):1053-1063. PubMed ID: 29282311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative dose-responses of recombinant human IL-2 and IL-7 on STAT5 phosphorylation in CD4+FOXP3- cells versus regulatory T cells: a whole blood perspective.
    Dupont G; Demaret J; Venet F; Malergue F; Malcus C; Poitevin-Later F; Morel J; Monneret G
    Cytokine; 2014 Sep; 69(1):146-9. PubMed ID: 24947990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural and inducible Tregs in swine: Helios expression and functional properties.
    Käser T; Mair KH; Hammer SE; Gerner W; Saalmüller A
    Dev Comp Immunol; 2015 Apr; 49(2):323-31. PubMed ID: 25511662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells.
    Shan J; Feng L; Sun G; Chen P; Zhou Y; Xia M; Li H; Li Y
    Immunobiology; 2015 Apr; 220(4):510-7. PubMed ID: 25468562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of IL-2 family cytokines on activation and function of naturally occurring regulatory T cells.
    Wuest TY; Willette-Brown J; Durum SK; Hurwitz AA
    J Leukoc Biol; 2008 Oct; 84(4):973-80. PubMed ID: 18653463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-beta1-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease.
    Su H; Ye DQ; Wang BL; Fang XH; Chen J; Wang Q; Li WX; Zhang N
    Br J Dermatol; 2008 Jun; 158(6):1197-209. PubMed ID: 18410422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.